Contact the Editorial Team

Correspondence

Avenger Peptides is glad to hear about the research record: a citation quoted inaccurately, a regulatory status that has changed, or a peer-reviewed study on BPC-157, TB-500, GHK-Cu, or KPV that belongs on the references page. Corrections that improve accuracy are the most useful mail that arrives, and each is read with care.

The notes easiest to act on name three things: the page in question, the exact passage, and the supporting citation — a DOI or PubMed ID wherever possible. That lets a proposed change be checked against its source efficiently.

Editorial mailbox: editors@avengerpeptides.com

Outside the guide's reach

A few things sit outside what the site can help with — flagged so no message waits on an answer it will never get. Avenger Peptides is a field guide to literature, not a clinic or a vendor, so it cannot:

• Advise on, endorse, or comment on human use of any peptide covered here.
• Name a dose, schedule, or route for any individual.
• Diagnose a condition or judge whether a finding fits a specific person.
• Sell, source, recommend, or help you locate any compound from any supplier.
• Field anti-doping questions from athletes about these compounds, several of which are prohibited in sport.

Anyone after clinical guidance should consult a licensed clinician in their own jurisdiction. Replies to correspondence are not guaranteed and may lag; the mailbox is checked periodically.